Histological Subtype of Ovarian Cancer as a Determinant of Sensitivity to Formamidine Derivatives of Doxorubicin - in Vitro Comparative Studies with SKOV-3 and ES-2 Cancer Cell Lines |
Denel-Bobrowska, M.
(Department of Medical Biophysics, Institute of Biophysics, Faculty of biology and Environmental Protection, University of Lodz)
Lukawska, M (Department of Modified Antibiotics, Institute of Biotechnology and Antibiotics) Oszczapowicz, I (Department of Modified Antibiotics, Institute of Biotechnology and Antibiotics) Marczak, A (Department of Medical Biophysics, Institute of Biophysics, Faculty of biology and Environmental Protection, University of Lodz) |
1 | Xue X, Yu JL, Sun DQ, et al (2014). Curcumin induces apoptosis in SGC-7901 gastric adenocarcinoma cells via regulation of mitochondrial signaling pathways. Asian paci J Prev, 15, 3987-92. DOI |
2 | Zwaal RF, Comfurius P, Bevers EM (2005). Surface exposure of phosphatidylserine in pathological cells. Life Sci, 62, 971-88. DOI |
3 | Anglesio MS, Carey MS, Kobel M, et al (2011). Clear cell carcinoma of the ovary: a report from the first Ovarian Clear Cell Symposium, June 24th, 2010. Gynecologic Oncol, 121, 407-15. DOI |
4 | Goldar S, Khaniani MS, Derakhshan SM, et al (2015). Molecular mechanisms of apoptosis and roles in cancer development and treatment. Asian Pac J Cancer Prev, 16, 2129-44. DOI |
5 | Aubry JP, Blaecke A, Lecoanet-Henchoz S, et al (1999). Annexin V used for measuring apoptosis in the early events of cellular cytotoxicity. Cytometry, 37, 197-204. DOI |
6 | Bellarosa D, Ciucci A, Bullo A, et al (2001). Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines. J Pharmacol Experimental Therapeutics, 296, 276-83. |
7 | Domcke S, Sinha R, Levine DA, et al (2013). Evaluating cell lines as tumour models by comparison of genomic profiles. Nature communications, 4, 2126. DOI |
8 | Dubbelboer IR, Lilienberg E, Ahnfelt E, et al (2014). Treatment of intermediate stage hepatocellular carcinoma: a review of intrahepatic doxorubicin drug-delivery systems. Therapeutic Delivery, 5, 447-66. DOI |
9 | Gajek A, Denel-Bobrowska M, Rogalska A, et al (2015). Early activation of apoptosis and caspase-independent cell death plays an important role in mediating the cytotoxic and genotoxic effects of WP 631 in ovarian cancer cells. Asian Pac J Cancer Prev, 16, 8503-12. |
10 | Koceva-Chyla A, Jedrzejczak M, Skierski J, et al (2005). Mechanisms of induction of apoptosis by anthraquinone anticancer drugs aclarubicin and mitoxantrone in comparison with doxorubicin: relation to drug cytotoxicity and caspase-3 activation. Apoptosis : an international J Programmed Cell Death, 10, 1497-514. DOI |
11 | Lee YY, Kim TJ, Kim MJ, et al (2011). Prognosis of ovarian clear cell carcinoma compared to other histological subtypes: A meta-analysis. Gynecologic Oncol, 122, 541-7. DOI |
12 | Oszczapowicz I, Wasowska M, Oszczapowicz J, et al (2005). Nowe pochodne antybiotykow antracyklinowych, sposob ich wytwarzania oraz zawierajacy je srodek farmaceutyczny". Polish Patent nb. 210494. |
13 | Lopes-Coelho F, Gouveia-Fernandes S, Goncalves LG, et al (2015). HNFlbeta drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC). Tumour Biol, 37, 4813-29 |
14 | Marczak A, Denel-Bobrowska M, Rogalska A, et al (2014). Cytotoxicity and induction of apoptosis by formamidinodoxorubicins in comparison to doxorubicin in human ovarian adenocarcinoma cells. Environmental Toxicology Pharmacol, 39, 369-83. |
15 | Moisan F, Francisco EB, Brozovic A, et al (2014). Enhancement of paclitaxel and carboplatin therapies by CCL2 blockade in ovarian cancers. Molecular Oncol, 8, 1231-9. DOI |
16 | Shan Z, Feng-Nian R, Jie G, et al (2012). Effects of valproic acid on proliferation, apoptosis, angiogenesis and metastasis of ovarian cancer in vUro and in vivo. Asian Pac J Prev, 13, 3977-82. DOI |
17 | Sun Y, Liu JH, Jin L, et al (2015). Effect of autophagy-related beclinl on sensitivity of cisplatin-resistant ovarian cancer cells to chemotherapeutic agents. Asian Pac J Prev, 16, 2785-91. DOI |
18 | Sun ZL, Tang YJ, Wu WG, et al (2013). AZD1480 can inhibit the biological behavior of ovarian cancer SKOV3 cells in vitro. Asia Pac J Cancer Prev, 14, 4823-7. DOI |
19 | Szwed M, Matusiak A, Laroche-Clary A, et al (2014). Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells. Toxicol In Vitro, 28, 187-97. DOI |
20 | Tamada Y, Takeuchi H, Suzuki N, et al (2007). Biological and therapeutic significance of MUC1 with sialoglycans in clear cell adenocarcinoma of the ovary. Cancer Sci, 98, 1586-91. DOI |